Division of Pharmacology and Toxicology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India-243122
*Corresponding author Email: subhaparida1210@gmail.com
Online Published on 11 November, 2025.
Obesity is a significant risk factor for adverse reproductive outcomes, with leptin—an adipokine elevated in obesity—implicated in modulating uterine contractility through Maxi potassium (BKCa) channels. This study aimed to assess the role of Kz channels other than BKCa in leptin-induced uterine relaxation during late pregnancy in mice. Uterine strips from late pregnant Swiss albino mice were subjected to cumulative concentration–response curves to leptin (10{ 1p to 10{ v M) in the presence of potassium channel blockers: 4-aminopyridine (4-AP, Kv), barium chloride (BaCl, , Kir2.1), and glibenclamide (KATP). Isometric contractions were recorded, and changes in maximal uterine inhibition (Emax) and potency (pD2) were evaluated. Neither Kv nor Kir2.1 channel blockade using 4-aminopyridine (4-AP) and barium chloride (BaCl2), respectively, significantly affected basal contractility or leptin-induced uterine relaxation. However, glibenclamide significantly reduced (p<0.05) the potency of leptin (pD2: 7.25 ± 0.26, n=6 vs. 8.58 ± 0.33, n=6) without altering Emax, suggesting a modulatory role of KATP channels in leptin responsiveness. While Kv and Kir2.1 channels appear to have minimal involvement, KATP channels may regulate the sensitivity of uterine smooth muscle to leptin. These findings offer insight into the ionic mechanisms underlying uterine quiescence and could inform therapeutic strategies for obesity-related pregnancy complications.
Leptin, Potassium channels, KATP channels, Glibenclamide, Uterus, Late pregnancy